Catapres Tablets 100 micrograms

দেশ: আয়ার্লণ্ড

ভাষা: ইংরেজি

সূত্র: HPRA (Health Products Regulatory Authority)

সক্রিয় উপাদান:

Clonidine hydrochloride

থেকে পাওয়া:

Glenwood GmbH

এটিসি কোড:

C02AC; C02AC01

INN (আন্তর্জাতিক নাম):

Clonidine hydrochloride

ডোজ:

100 microgram(s)

ফার্মাসিউটিকাল ফর্ম:

Tablet

থেরাপিউটিক এলাকা:

Imidazoline receptor agonists; clonidine

অনুমোদন অবস্থা:

Marketed

অনুমোদন তারিখ:

1979-04-01

তথ্য লিফলেট

UK_Catapres Tablets
Page 1 / 5
PACKAGE LEAFLET: INFORMATION FOR THE USER
CATAPRES
®
TABLETS
100 MICROGRAMS
(clonidine hydrochloride)
READ ALL OF THIS LEAFLET CAREFULLY BEFORE YOU START TAKING THIS
MEDICINE.
•
Keep this leaflet. You may need to read it again.
•
If you have any further questions, ask your doctor or pharmacist.
•
This medicine has been prescribed for you. Do not pass it on to
others. It may harm them,
even if their symptoms are the same as yours.
•
If any of the side effects gets troublesome or serious, or if you
notice any side effects not listed
in this leaflet, please tell your doctor or pharmacist.
IN THIS LEAFLET:
1.
What CATAPRES Tablets are and what they are used for
2.
Before you take CATAPRES Tablets
3.
How to take CATAPRES Tablets
4.
Possible side effects
5.
How to store CATAPRES Tablets
6.
Further information
1. WHAT CATAPRES TABLETS ARE AND WHAT THEY ARE USED FOR
CATAPRES Tablets contain a medicine called clonidine. This belongs to
a group of medicines called
antihypertensives.
CATAPRES is used to lower high blood pressure (to treat hypertension).
2. BEFORE YOU TAKE CATAPRES TABLETS
DO NOT TAKE CATAPRES IF:
•
You are pregnant, likely to get pregnant or are breast-feeding
•
You are allergic (hypersensitive) to clonidine or any of the other
ingredients of CATAPRES
(see section 6: Further information)
•
You have a slow heart rate due to heart problems
Do not take this medicine if any of the above apply to you. If you are
not sure, talk to your doctor or
pharmacist before using CATAPRES.
TAKE SPECIAL CARE WITH CATAPRES
Check with your doctor or pharmacist before taking CATAPRES if:
•
You have Raynaud’s disease (a problem with circulation to the
fingers and toes) or other
blood circulation problems, including circulation to the brain
•
You have heart or kidney problems
•
You have or have ever had depression
•
You have constipation
•
You have a nerve disorder that causes your hands and feet to feel
different (‘altered
sensation’) or low blood pressure when you st

পণ্য বৈশিষ্ট্য

Health Products Regulatory Authority
25 May 2023
CRN00DKSN
Page 1 of 6
SUMMARY OF PRODUCT CHARACTERISTICS
1 NAME OF THE MEDICINAL PRODUCT
Catapres Tablets 100 micrograms
2 QUALITATIVE AND QUANTITATIVE COMPOSITION
Each tablet contains clonidine hydrochloride 100 micrograms.
For excipients see 6.1
3 PHARMACEUTICAL FORM
Tablet,
White, round, flat, bevel-edged tablets impressed with the motif 01C
on one side.
01C
4 CLINICAL PARTICULARS
4.1 THERAPEUTIC INDICATIONS
Catapres tablets are indicated for the treatment of hypertension that
has failed to respond adequately to other
anti-hypertensives.
4.2 POSOLOGY AND METHOD OF ADMINISTRATION
Adults only:
The usual initial dosage is 0.05 to 0.10 mg three times daily with
subsequent gradual increments to the level of optimal control
generally in the daily dose range of 0.3 to 1.2 mgin divided doses
although higher levels may be required.
Should clonidine be added to other anti-hypertensive therapy dosage of
the latter should be gradually reduced as the
clonidine is introduced.
Patients undergoing anaesthesia should continue their Catapres
treatment before, during and after anaesthesia using oral or
intravenous administration according to individual circumstances.
_PAEDIATRIC POPULATION:_
There is insufficient evidence for the application of clonidine in
children and adolescents younger than 18 years. Therefore the
use of clonidine is not recommended in paediatric subjects under 18
years.
_RENAL INSUFFICIENCY:_
Dosage must be adjusted
- according to the individual antihypertensive response which can show
high variability in patients with renal insufficiency
- according to the degree of renal impairment
4.3 CONTRAINDICATIONS
Catapres should not be used in children (please refer to section 4.4
Special Warnings and Precautions for Use) or in patients
with known hypersensitivity to the active ingredient or other
components of the product and in patients with severe
bradyarrhythmia resulting from either sick sinus syndrome or AV block
of 2nd or 3rd degree.
In case of rare hereditary